妊娠中高血糖が出生結果悪化に関連(Elevated blood sugar levels during pregnancy may result in poorer birth outcomes)

ad

2026-05-06 ペンシルベニア州立大学(Penn State)

Pennsylvania State Universityの研究チームは、妊娠中の血糖値上昇が、出生後の子どもの発達や健康状態に悪影響を与える可能性を示した。研究では、妊婦の血糖値データと子どもの認知機能・発達指標を長期的に追跡解析し、妊娠糖尿病や軽度の高血糖状態でも、子どもの学習能力や神経発達に影響を及ぼす可能性が確認された。高血糖環境は胎児期の脳発達や代謝制御に変化を与え、将来的な肥満、糖尿病、注意機能低下などのリスク増加につながる可能性があるという。研究者らは、妊娠中の血糖管理が母体だけでなく次世代の健康維持にも重要だと強調している。また、早期スクリーニングや食事・運動介入による予防の重要性も指摘された。今回の成果は、周産期医療や母子保健政策の改善に役立つ知見として期待されている。

妊娠中高血糖が出生結果悪化に関連(Elevated blood sugar levels during pregnancy may result in poorer birth outcomes)
In this study, 17% of women had elevated blood sugar without a gestational diabetes diagnosis. Credit: LumiNola/Getty Images. All Rights Reserved.

<関連情報>

母体血糖値、妊娠糖尿病、胎​​児発育および妊娠週数に関する有害転帰との関連性:後向きコホート研究 The relationship between maternal glucose concentrations, gestational diabetes mellitus, and adverse fetal growth and gestational age outcomes: a retrospective cohort study

Amrita Arcot, Kelly Gallagher, Jeffery A Goldstein, Alison D Gernand
The American Journal of Clinical Nutrition  Available online: 16 March 2026
DOI:https://doi.org/10.1016/j.ajcnut.2026.101280

Abstract

Background

Gestational diabetes mellitus (GDM) is defined as hyperglycemia or glucose intolerance in pregnancy and no history of diagnosed type 1 or type 2 diabetes mellitus. The relationship between elevated glucose without GDM and pregnancy outcomes is not well understood.

Objectives

To examine the relationships between glucose challenge test (GCT) concentrations and GDM with fetal growth and gestational age at birth.

Methods

We conducted a retrospective cohort study using secondary medical record data from Northwestern Memorial Hospital (n = 10,899). The data were from pregnancies where the placenta was sent for pathology. We examined birth weight z-score, gestational age at birth, birth weight to placental weight ratio, small for gestational age, large for gestational age (LGA), and preterm birth. We categorized glucose groups: pass GCT/no GDM (control), fail GCT/no GDM, and GDM. We adjusted linear and log-binomial regression models for maternal age, race, parity, gestational age at birth, and infant sex.

Results

Of the placentas sent to pathology, 5% were from pregnancies diagnosed with GDM. Birth weight z-score was marginally higher in the fail GCT/no GDM (adjusted mean difference: 0.14; 95% confidence interval (CI): 0.09, 0.19) and the GDM group (0.19; 95% CI: 0.11, 0.29), compared with the control. The GDM group had a nearly 3-day mean difference in gestational age (‒2.88; 95% CI: ‒4.00, ‒1.77). Patients in the fail GCT/no GDM group had a higher risk of LGA and preterm birth, by 41% (95% CI: 22%, 63%) and 27% (95% CI: 12%, 44%), respectively. Patients in the GDM group had a 71% (95% CI: 34%, 216%) higher risk of LGA, but preterm birth risk was not significantly different.

Conclusions

GDM was associated with the highest mean birthweight z-score, the shortest mean gestational age, and a higher risk of LGA. Higher glucose concentrations and failed GCT without GDM were associated with a higher risk of preterm birth and LGA.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました